Hydroxypropyl-guar gellable lubricant eye drops for dry eye treatment

Expert Opinion on Pharmacotherapy

Volumn 9, Issue 8, 2008, Pages 1431-1436

  Petricek, Igor ^a   Berta, András ^b   Higazy, Mohamed T ^c   Németh, János ^d   Prost, Marek E ^e,f  

^a KBC Zagreb   (Croatia)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c BENHA UNIVERSITY   (Egypt)

^d SEMMELWEIS UNIVERSITY   (Hungary)

^e MILITARY INSTITUTE OF AVIATION MEDICINE   (Poland)

^f Center for Paediatric Ophthalmology   (Poland)

Author keywords

Artificial tear; Dry eye; Hydroxypropyl guar; Systane

Indexed keywords

ARTIFICIAL TEAR; BENZALKONIUM CHLORIDE; CALCIUM; CARBOXYMETHYLCELLULOSE; EYE DROPS; GENTEAL; GLYCEROL; GUAR GUM; HYDROXYPROPYLCELLULOSE; HYDROXYPROPYLGUAR; HYDROXYPROPYLMETHYLCELLULOSE; LUBRICATING AGENT; MAGNESIUM; OPTIVE; POLYSORBATE 80; POTASSIUM; PURITE; REFRESH ENDURA; REFRESH LIQUIGEL; REFRESH TEARS; SODIUM; SYSTANE; VISINE TEARS; ZINC ION; HYDROXYPROPYL GUAR; POLYSACCHARIDE;

ABNORMAL SENSATION; CONTACT LENS; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG MIXTURE; DRUG RESPONSE; DRUG STABILITY; DRY EYE; EYE PROTECTION; GEOGRAPHIC DISTRIBUTION; HUMAN; LUBRICATION; PREVALENCE; REVIEW; TEAR FILM; CHEMISTRY; CLINICAL TRIAL; GEL; PH; QUALITY OF LIFE; TOPICAL DRUG ADMINISTRATION; VISCOSITY;

ADMINISTRATION, TOPICAL; CLINICAL TRIALS AS TOPIC; DRY EYE SYNDROMES; GELS; HUMANS; HYDROGEN-ION CONCENTRATION; LUBRICATION; OPHTHALMIC SOLUTIONS; POLYSACCHARIDES; QUALITY OF LIFE; VISCOSITY;

EID: 45549104385     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.9.8.1431     Document Type: Review

References (25)

1. Schein OD, Tirlsch JM, Munoz B, et al. Relation between signs and symptoms of dry eye in the elderly - a population based perspective. Ophthalmology 1997;104(9):1395-401
2. Holly FJ, Lemp MA. Tear physiology and dry eyes. Surv Ophthalmol 1977;22(2):69-87
3. Begley CG, Caffery B, Chalmers RL, Mitchell GL. Use of dry eye questionnaire to measure symptoms of ocular irritation in subjects with aqueous tear deficient dry eye. Cornea 2002;21(7):664-70
4. Doughty MJ, Fonn D, Richter D, et al. A patient questionnaire approach to estimating the prevalence of dry eye symptoms in subjects presenting to optometric practices accross Canada. Optom Vis Sci 1997;74(8):624-31
5. Jacobsson LT, Axell TE, Hansen BU, et al. Dry eyes or mouth-an epidemiological study in Swedish adults, with special reference to primary Sjoegren's syndrome. J Autoimmun 1989;2:521-7
6. Hikichi T, Yoshida A, Fukui Y, et al. Prevalence of dry eye in Japanese eye centers. Graefes Arch Clin Exp Ophthalmol 1995;233:555-8
7. Bjerrum KB. Keratoconjunctivitis sicca and primary Sjoegren's syndrome in a Danish population aged 30-60 years. Acta Ophthalmol Scand 1997;75:281-6
8. Schein OD, Munoz B, Tielsch JM, et al. Prevalence of dry eye among the elderly. Am J Ophthalmol 1997;124:723-8
9. Moss SE, Klein R, Klein BE. Prevalence and risk factors for dry eye syndrome. Arch Ophthalmol 2000;118:1264-8
10. Petricek I, Prost M, Popova A. The differential diagnosis of red eye: a survey of medical practitioners from Eastern Europe and the Middle East. Ophthalmologica 2006;220:229-37
11. Ketelson HA, Asgharian B, Chowhan M, Meadows D. Characterization of physical property attributes for polymer systems used in artificial tear products. ARVO 2004
12. Kesacan S, Proudhomme RK. Macromolecules 1992;25:2026-32
13. Bello JB, Muller AJ, Saez AE. Polym Bull 1996;36:111-8
14. Yamada M, Mochizuki H, Kawai M, et al. Fluorophotometric measurement of pH of human tears in vivo. Curr Eye Res 1997;16(5):482-6
15. Maurice DM. The Charles prentice award lecture 1989: the physiology of tears. Optom Vis Science 1990;67(6):391-9
16. Ubels JL, Clousing DP, Van Haitsma TA, et al. Pre-clinical investigation of the efficacy of an artificial tear solution containing hydroxypropyl-guar as a gelling agent. Curr Eye Res 2004;28(6):437-44
17. Chen H, Gan O, Meadows D. Evaluation of lubricity of marketed dry eye products using a tissue-on-tissue model. Presented at the American Optometry Association, Boston; 2007
18. Christensen MT, Cohen S, Rinehart J, et al. Clinical evaluation of an HP-guar gellable lubricant eye drop for the relief of dryness of the eye. Curr Eye Res 2004;28(1):55-62
19. Christensen MT, Stein J, Stone R, Meadows D. Evaluation of tear film break-up time extension by artificial tears in dry eye patients. Abst Opt Vis Sci 2003;80(12s):106
20. Hartstein I, Khwarg S, Przydryga J. An open-label evaluation of HP-Guar gellable lubricant eye drops for the improvement of dry eye signs and symptoms in a moderate dry eye adult population. Curr Med Res Opin 2005;21(2):255-60
21. D'Arienzo P, Ousler GW, Schindelar MR. A comparison of two marketed artificial tears in improvement of tear film stability as measured by Tear Film Break-Up Time (TFBUT) and Ocular Protection Index (OPI). Tear film and ocular surface. September 2007, Sicily, Italy. Data on file. Available from: www.AlconLabs.com
22. Korb DR, Herman JP, Greiner JV, et al. Lid wiper epitheliopathy and dry eye symptoms. Eye Contact Lens 2005;31(1):2-8
23. Meyer AE, Baier RE, Chen H, Chowhan M. Tissue-on-tissue testing of dry eye formulations for reduction of bioadhesion. J Adhesion 2006;82:607-27
24. Aguilar A, Cohen SM, Christensen MT. Duration of systane® lubricant eye drops efficacy in dry eye patients. Data on file. Available from: www.AlconLabs.com
25. Cohen SM, Potter WB, Christensen M, Kern J. Prospective case history study using Systane® lubricant eye drops to help reduce symptoms of dry eye associated with contact lens wear. American Optometric Association 2004. Data on file. Available from: www.AlconLabs.com